Type 2 Diabetes Trial, Not Yet Recruiting NCT07666529 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Not Yet Recruiting

NCT07666529
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Adults between 18 and 75 years of age
  • People who have been diagnosed with type 2 diabetes for more than 6 months, based on the International Diabetes Federation's diagnostic criteria
  • People whose type 2 diabetes is not well controlled, with a blood sugar measure called HbA1c between 7.5% and 10.5%
  • People whose diabetes treatment has been stable for at least 3 months, meaning no diabetes medicines have been started or stopped, and any background insulin dose has not changed by more than 50% from the starting dose
  • People who have all their teeth up to and including the second premolars (the smaller back teeth), including teeth that have been replaced by fixed bridges or dental implants; teeth removed for orthodontic reasons or due to never having developed are not counted against this
  • People who are missing most or all of their back molar teeth, specifically those with no functional molar pairs that are not covered by a partial denture, or those with only one functional molar pair remaining (wisdom teeth are not counted in this assessment)

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People diagnosed with diabetes less than 6 months ago, those using intensive insulin therapy (3 or more injections per day), or those using an insulin pump
  • People with type 1 diabetes
  • People with type 2 diabetes whose HbA1c blood sugar measure is above 10.5%
  • People with other serious health conditions that would make part of the dental treatment unsafe — such as advanced kidney disease or a stroke in the past 6 months — or conditions that affect the ability to chew
  • People who smoke more than 10 cigarettes per day
  • People whose jaw or bite structure makes part of the planned dental treatment unsuitable, such as severe bone loss, not enough space for dental work, bite alignment problems, or harmful habits like teeth grinding
  • People with severe gum disease (classified as Stage III or IV, Grade C)
  • People with cancerous or pre-cancerous areas in the mouth
  • People with an allergy to the anaesthetics or antibiotics needed for dental surgery
  • Women who are pregnant or breastfeeding
  • People currently taking part in another interventional clinical study, or who are within a required waiting period after a previous clinical study
  • People who are not affiliated with a social security scheme (confirm with trial site, as this appears to relate to French healthcare coverage requirements)
  • People receiving State Medical Aid (AME), which is a specific French government healthcare assistance program
  • People who are in legal custody or under legal protection measures
  • People who are unwilling or unable to provide written consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33 1 53 11 18 00

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 November 2026
Est. completion
15 August 2030

Primary endpoints

Change in HbA1c (%) from baseline (randomization) to 9 months post-randomization.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov